Walleye Capital’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,385	Closed	-$745	–	1532
2021 Q1	$745	Buy	+1,385	New	+$745	0.04%	392